1-20 of 25
adverse effects
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Beyond JAK-STAT: novel therapeutic targets in Ph-negative MPN

Aaron T. Gerds
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 407–414.
https://doi.org/10.1182/hematology.2019000048
Published: 2019
Journal Articles

Moving immunotherapy into the front line in ALL

Amanda Winters, Lia Gore
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2019) 2019 (1): 209–217.
https://doi.org/10.1182/hematology.2019000017
Published: 2019
Journal Articles

The argument for using imatinib in CML

Simone Claudiani, Jane F. Apperley
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2018) 2018 (1): 161–167.
https://doi.org/10.1182/asheducation-2018.1.161
Published: 2018
Journal Articles

Management of multiple myeloma in the relapsed/refractory patient

Pieter Sonneveld
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 508–517.
https://doi.org/10.1182/asheducation-2017.1.508
Published: 2017
Journal Articles

Optimizing the care model for an uncomplicated acute pain episode in sickle cell disease

Paul Telfer, Banu Kaya
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2017) 2017 (1): 525–533.
https://doi.org/10.1182/asheducation-2017.1.525
Published: 2017
Journal Articles

Second-line therapies in immune thrombocytopenia

Rachael F. Grace, Cindy Neunert
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 698–706.
https://doi.org/10.1182/asheducation-2016.1.698
Published: 2016
Journal Articles

Pharmacogenomics of acute lymphoid leukemia: new insights into treatment toxicity and efficacy

Mary V. Relling, Laura B. Ramsey
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 126–130.
https://doi.org/10.1182/asheducation-2013.1.126
Published: 2013
Journal Articles

Phase 4 research: what happens when the rubber meets the road?

Mark Crowther
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 15–18.
https://doi.org/10.1182/asheducation-2013.1.15
Published: 2013
Journal Articles

Vascular Effects of the Red Blood Cell Storage Lesion

John D. Roback
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 475–479.
https://doi.org/10.1182/asheducation-2011.1.475
Published: 2011
Journal Articles

Advances in Antiplatelet Therapy

Alan D. Michelson
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 62–69.
https://doi.org/10.1182/asheducation-2011.1.62
Published: 2011
Journal Articles

Immunomodulating Drugs in Myelodysplastic Syndromes

Lionel Adès, Pierre Fenaux
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 556–560.
https://doi.org/10.1182/asheducation-2011.1.556
Published: 2011
Journal Articles

What is the Benefit of Maintenance Therapy with Lenalidomide or Bortezomib after Autologous Stem Cell Transplantation in Multiple Myeloma and What is the Risk of Developing a Secondary Primary Malignancy?

Emma Scott, Donna Reece
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 205–207.
https://doi.org/10.1182/asheducation-2011.1.205
Published: 2011
Journal Articles

Educational Session: Managing Chronic Myeloid Leukemia as a Chronic Disease

Andreas Hochhaus
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2011) 2011 (1): 128–135.
https://doi.org/10.1182/asheducation-2011.1.128
Published: 2011
Journal Articles

Update on Iron Chelators in Thalassemia

Ellis J. Neufeld
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 451–455.
https://doi.org/10.1182/asheducation-2010.1.451
Published: 2010
Journal Articles

Treatment of Pediatric Chronic Myeloid Leukemia in the Year 2010: Use of Tyrosine Kinase Inhibitors and Stem-Cell Transplantation

Meinolf Suttorp, Frédéric Millot
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 368–376.
https://doi.org/10.1182/asheducation-2010.1.368
Published: 2010
Journal Articles

Long-Term Physiological Side Effects After Allogeneic Bone Marrow Transplantation

Mohamad Mohty, Jane F. Apperley
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 229–236.
https://doi.org/10.1182/asheducation-2010.1.229
Published: 2010
Journal Articles

Supportive care and chelation therapy in MDS: are we saving lives or just lowering iron?

Heather A. Leitch, Linda M. Vickars
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2009) 2009 (1): 664–672.
https://doi.org/10.1182/asheducation-2009.1.664
Published: 2009
Journal Articles

Factor XI deficiency—resolving the enigma?

Paula H. B. Bolton-Maggs
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2009) 2009 (1): 97–105.
https://doi.org/10.1182/asheducation-2009.1.97
Published: 2009
Journal Articles

Initial treatment for patients with CML

John M. Goldman
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2009) 2009 (1): 453–460.
https://doi.org/10.1182/asheducation-2009.1.453
Published: 2009
Journal Articles

Therapeutic potential of JAK2 inhibitors

Srdan Verstovsek
Journal: Hematology
Hematology Am Soc Hematol Educ Program (2009) 2009 (1): 636–642.
https://doi.org/10.1182/asheducation-2009.1.636
Published: 2009